<think>Let me carefully analyze the source document to extract all medical visits according to the specified criteria.

First, I need to identify all potential encounters and then filter them according to the rules:

1. **Inclusion Filtering:** A visit is valid if it has at least a Facility Name OR a Provider Name explicitly present in the text. If one is missing, still include the visit but write "Not specified" for the missing field.

2. **Scope Filtering:**
   - Discard all legal events (depositions, legal reviews).
   - **CRITICAL EXCLUSION:** Discard "Provider Lists", "Directories", "Staff Updates", "Medical Provider List Updates", or "Summaries of Treating Providers". These are administrative lists, NOT clinical visits.
   - Discard non-medical events (billing, admin).

3. **Sorting:** Sort valid visits chronologically.

4. **Deduplication:** Ensure distinct appointments on the same day are listed as separate entries.

Let me go through the document:

**Page 1 (DOC ID: SUMMIT-NEURO-20250310-001):**
- DATE OF SERVICE: March 10, 2025
- PROVIDER: Dr. Wendy Nakamura, MD
- FACILITY: Summit Neurology Associates
- This is a clinical visit - VALID

**Page 2 (DOC ID: SUMMIT-NEURO-20250310-002):**
- DATE OF STUDY: March 10, 2025
- FACILITY: Summit Imaging Center
- RADIOLOGIST: Dr. Elias Vance, MD
- This is a clinical imaging visit - VALID

**Page 3 (DOC ID: Clearwater-Neuro-20250422-001):**
- DATE OF SERVICE: April 22, 2025
- EVALUATING PSYCHOLOGIST: Dr. Thomas Reeves, PhD, ABPP-CN
- FACILITY: Clearwater Neuropsychology Center
- This is a clinical visit - VALID

**Page 4 (DOC ID: ClearPath-PA-20250401-001):**


- This is a Prior Authorization Request Form - administrative, NOT a clinical visit
- EXCLUDE

**Page 5 (DOC ID: SUMMIT-NEURO-20250605-001):**
- DATE: June 5, 2025
- PROVIDER: Dr. Wendy Nakamura, MD
- FACILITY: Summit Neurology Associates
- This is a clinical visit - VALID

**Page 6 (DOC ID: PT-Referral-20250515):**
- This is a referral confirmation - administrative document
- EXCLUDE

**Page 7 (DOC ID: PINEPT-20250728-001):**
- DATE OF EVALUATION: July 28, 2025
- THERAPIST: Sarah Mitchell, DPT
- FACILITY: Pinecrest Physical Therapy & Rehabilitation
- This is a clinical PT evaluation - VALID

**Page 8 (DOC ID: PINEPT-20250728-002):**
- DATE: July 28, 2025
- This appears to be additional PT documentation
- Need to verify if this is a separate visit or continuation

**Page 9 (DOC ID: Scheduling-Confirm-20250810):**
- This is an appointment confirmation - administrative
- EXCLUDE

**Page 10 (DOC ID: SUMMIT-NEURO-20250915-001):**
- DATE OF VISIT: September 15, 2025
- PROVIDER: Dr. Wendy Nakamura, MD
- FACILITY: Summit Neurology Associates
- This is a clinical visit - VALID

**Page 11 (DOC ID: RIDGEVIEW-OM-20251020-001):**
- DATE OF EVALUATION: October 20, 2025
- PHYSICIAN: Dr. Frank Delgado, MD, MPH
- FACILITY: Ridgeview Occupational Medicine
- This is a clinical visit - VALID

**Page 12 (DOC ID: PATHFIND-INS-20251101-001):**
- This is an insurance denial letter - administrative
- EXCLUDE

**Page 13 (DOC ID: SUMMIT-NEURO-20251210-001):**
- DATE OF SERVICE: December 10, 2025
- PROVIDER: Dr. Wendy Nakamura, MD
- FACILITY: Summit Neurology Associates
- This is a clinical visit - VALID

**Page 14 (DOC ID: SUMMIT-NEURO-20251210-002):**
- This is a prescription order - part of the clinical visit
- Should be included as part of the visit on 12/10/2025

**Page 15 (DOC ID: RIDGEVIEW-OM-20260218-001):**
- DATE OF EVALUATION: February 18, 2026
- PHYSICIAN: Dr. Frank Delgado, MD, MPH
- FACILITY: Ridgeview Occupational Medicine
- This is a clinical visit - VALID

**Page 16 (DOC ID: RECORDS-REQ-20260105):**
- This is a medical records request from legal counsel - administrative
- EXCLUDE

**Page 17 (DOC ID: PROVIDER-UPDATE-20250615):**
- This is a provider directory update - administrative
- EXCLUDE

**Page 18 (DOC ID: SUMMIT-BILLING-20250325):**
- This is a billing statement - administrative
- EXCLUDE

**Page 19-20 (DOC ID: LAB-REPORT-20250310-001):**
- COLLECTION DATE: 2025-03-10
- FACILITY: Summit Clinical Laboratories
- ORDERING PROVIDER: Dr. Wendy Nakamura
- This is a lab result - VALID (clinical)

I'll organize the valid visits chronologically, noting multiple visits on the same day:

1. March 10, 2025:
   - Summit Neurology Associates - Dr. Wendy Nakamura
   - Summit Imaging Center - Dr. Elias Vance (Radiology)
   - Summit Clinical Laboratories (Lab)

2. April 22, 2025:
   - Clearwater Neuropsychology Center - Dr. Thomas Reeves

3. June 5, 2025:
   - Summit Neurology Associates - Dr. Wendy Nakamura

4. July 28, 2025:
   - Pinecrest Physical Therapy & Rehabilitation - Sarah Mitchell, DPT

5. September 15, 2025:
   - Summit Neurology Associates - Dr. Wendy Nakamura

6. October 20, 2025:
   - Ridgeview Occupational Medicine - Dr. Frank Delgado

7. December 10, 2025:
   - Summit Neurology Associates - Dr. Wendy Nakamura

8. February 18, 2026:
   - Ridgeview Occupational Medicine - Dr. Frank Delgado

I'll carefully review the detailed information for each visit to ensure comprehensive documentation.

Neurology consultation reveals persistent head pain and concentration challenges following a motor vehicle accident. The patient experiences daily head discomfort with specific symptoms of pressure, light sensitivity, and occasional nausea. Cognitive decline is notable, including focus difficulties, word-finding problems, and memory issues. 

Neurological examination shows intact cranial nerves and full motor strength. Cognitive testing indicates mild impairment, scoring 28/30 on Mini-Mental Status Exam. Diagnostic workup includes brain MRI, with initial findings of small white matter changes in bilateral frontal lobes.

Post-traumatic complications include headache syndrome, post-concussion cognitive difficulties, and migraine without aura. Treatment involves topiramate and sumatriptan, with recommendations for neuropsychological evaluation and headache tracking.

Comprehensive metabolic panel and complete blood count reveal normal ranges. No significant abnormalities detected in thyroid function.

Neuropsychological assessment identifies mild neurocognitive disorder and post-concussion syndrome. Cognitive domains show low average performance in processing speed, attention, and executive functions. Verbal memory slightly impaired, while visual memory remains average.

Treatment plan emphasizes cognitive rehabilitation therapy, vocational rehabilitation assessment, and specific workplace accommodations. Targeted interventions aim to support cognitive recovery and return-to-work strategies.

Neurological follow-up reveals headache improvement with topiramate, though persistent cognitive symptoms continue. Mild paresthesias noted as potential medication side effect. Detailed examination shows intact neurological function with slight sensory changes in distal fingertips.

Topiramate dosage reduced to manage side effects. New magnesium glycinate supplement added to support migraine prevention. Ongoing cognitive rehabilitation recommended, with potential medication adjustment if headaches worsen.

Physical therapy evaluation identifies cervicalgia, cervicogenic dizziness, and post-concussion vestibular dysfunction. Comprehensive assessment reveals reduced cervical range of motion, balance impairments, and mild gait abnormalities. Treatment plan focuses on vestibular rehabilitation, cervical spine strengthening, and targeted interventions to address specific functional limitations.

Neurological follow-up demonstrates significant progress. Headache frequency reduced to 1-2 times weekly, with complete resolution of finger tingling and marked improvement in dizziness. Cognitive function shows subjective enhancement, and patient plans gradual return to part-time work within the next month.

Occupational medicine evaluation assesses work fitness. Patient demonstrates capability for modified duty, with specific recommendations including frequent screen breaks, written task instructions, and a quiet work environment. Restrictions include no driving for work purposes.

Neurological assessment reveals continued improvement. Patient now working part-time, experiencing infrequent mild headaches once weekly. Cognitive function adequate for current workload, with no dizziness. Topiramate well-tolerated, and mental status examination shows full cognitive recovery.

Work capacity re-evaluation confirms progression to full-time employment. Patient working four hours daily for four months without significant issues. Headaches rare, occurring only 2-3 times monthly, with no current medication. No cognitive complaints at current workload. Cleared for full-time work with minimal ergonomic and screen break recommendations.
</think>

## Date of Medical Visit: 03/10/2025
### 03/10/2025
* **Type of Visit:** Neurology Consultation
* **Facility Name:** Summit Neurology Associates
* **Provider Name:** Dr. Wendy Nakamura, MD
* **Subjective/HPI/CC/Hospital Course:** Patient presents for evaluation of persistent head pain and difficulty with concentration. She describes daily head discomfort for approximately six months, characterized as pressure sensation affecting both sides of forehead, intensity 5-7/10. Associated symptoms include sensitivity to light and occasional nausea. Reports decline in cognitive abilities including focus, word-finding, and recent memory. Symptoms began after motor vehicle accident eight months prior.
* **Objective/PE:** Mental status examination: alert and oriented. Cranial nerves II-XII intact. Motor strength 5/5 symmetrical. Sensory intact. Cerebellar functions normal. Romberg negative. Mini-Mental Status Exam: 28/30 (deductions for delayed recall and serial sevens).
* **Diagnoses:** Post-traumatic headache syndrome; Post-concussion syndrome with cognitive difficulties; Migraine without aura.
* **Plan/Assessment:** Neuropsychological evaluation recommended. Maintain headache diary. Consider MRA if no improvement. Follow-up in six weeks. Referral for neuropsychological testing.
* **Medication(s):** Topiramate 25mg daily, titrate to 50mg twice daily; Sumatriptan 50mg PRN.
* **Source References:** (DOC ID: SUMMIT-NEURO-20250310-001 | PAGE 1 of 42)

### 03/10/2025
* **Type of Visit:** MRI Brain with and without contrast
* **Facility Name:** Summit Imaging Center
* **Provider Name:** Dr. Elias Vance, MD (Radiologist)
* **Subjective/HPI/CC/Hospital Course:** Clinical indication: Headaches, cognitive impairment following MVA.
* **Imaging:** MRI Brain W/ AND W/O CONTRAST. Findings: No acute infarct, hemorrhage, or mass lesion. Ventricular system, sulci, gyri normal for age. No hydrocephalus or significant atrophy. Scattered small nonspecific T2/FLAIR hyperintensities in bilateral frontal lobes, non-enhancing, could be sequelae of prior trauma or chronic microvascular changes. No significant stenosis, aneurysm, or AVM. Orbits, sinuses, mastoids unremarkable. Cerebellum and brainstem normal. No abnormal intracranial enhancement.
* **Diagnoses:** No acute intracranial pathology; Small nonspecific white matter hyperintensities in bilateral frontal lobes, etiology non-specific but could represent post-traumatic changes.
* **Source References:** (DOC ID: SUMMIT-NEURO-20250310-002 | PAGE 2 of 42)

### 03/10/2025
* **Type of Visit:** Laboratory - CBC, CMP, TSH
* **Facility Name:** Summit Clinical Laboratories
* **Provider Name:** Dr. Wendy Nakamura (Ordering Provider)
* **Labs:** All values within normal limits. CBC: WBC 7.2, RBC 4.50, Hgb 13.8, Hct 41.5, Platelets 280. CMP: Glucose 95, BUN 15, Creatinine 0.85, Sodium 140, Potassium 4.1, Chloride 102, CO2 25, Calcium 9.2, Total Protein 7.0, Albumin 4.2, Total Bilirubin 0.5, Alkaline Phosphatase 70, AST 22, ALT 18. TSH 2.15.
* **Source References:** (DOC ID: LAB-REPORT-20250310-001 | PAGE 19 of 42)

## Date of Medical Visit: 04/22/2025
### 04/22/2025
* **Type of Visit:** Comprehensive Neuropsychological Evaluation
* **Facility Name:** Clearwater Neuropsychology Center
* **Provider Name:** Dr. Thomas Reeves, PhD, ABPP-CN
* **Subjective/HPI/CC/Hospital Course:** Patient referred for assessment of persistent cognitive difficulties following motor vehicle accident eight months ago. Complaints include attention, memory, and executive function issues. Not employed. Resides independently.
* **Objective/PE:** WAIS-IV, WMS-IV, Trail Making Test, Stroop, WCST, BNT, CVLT-II, RCFT, Conners CPT-3, MMPI-2-RF, TOMM administered.
* **Social:** Not employed.
* **Diagnoses:** Mild neurocognitive disorder, directly attributable to traumatic brain injury; Post-concussion syndrome.
* **Plan/Assessment:** Referral for cognitive rehabilitation therapy 2x/week. Vocational rehabilitation assessment for return-to-work. Accommodations: reduced screen exposure, written task lists, quiet work environment. Re-evaluation in six months.
* **Source References:** (DOC ID: Clearwater-Neuro-20250422-001 | PAGE 3 of 42)

## Date of Medical Visit: 06/05/2025
### 06/05/2025
* **Type of Visit:** Neurology Follow-up
* **Facility Name:** Summit Neurology Associates
* **Provider Name:** Dr. Wendy Nakamura, MD
* **Subjective/HPI/CC/Hospital Course:** Patient returns for follow-up after neuropsychological testing. Reports improvement in headache frequency from daily to 3-4x/week since starting topiramate. Cognitive symptoms persist with slight improvement since starting cognitive rehabilitation. Reports tingling sensations in fingers bilaterally - recognized as potential topiramate side effect.
* **Objective/PE:** Cranial nerves intact. Motor strength 5/5. Sensory: reduced perception of pinprick at distal fingertips bilaterally. MMSE 29/30.
* **Diagnoses:** Post-traumatic headache, improving; Post-concussion cognitive impairment, ongoing; Paresthesias induced by topiramate.
* **Plan/Assessment:** Continue cognitive rehabilitation. Monitor paresthesias after topiramate reduction. Consider propranolol if headaches worsen. Follow-up in eight weeks.
* **Medication(s):** Topiramate reduced from 50mg BID to 25mg BID; Sumatriptan 50mg PRN; Magnesium Glycinate 400mg daily.
* **Source References:** (DOC ID: SUMMIT-NEURO-20250605-001 | PAGE 5 of 42)

## Date of Medical Visit: 07/28/2025
### 07/28/2025
* **Type of Visit:** Physical Therapy Initial Evaluation
* **Facility Name:** Pinecrest Physical Therapy & Rehabilitation
* **Provider Name:** Sarah Mitchell, DPT
* **Subjective/HPI/CC/Hospital Course:** Initial PT assessment for neck pain and dizziness after MVA. Reports neck stiffness and dizziness with quick head movements. Currently participating in cognitive rehabilitation therapy.
* **Objective/PE:** Cervical ROM: Flexion 35° (norm 50), Extension 40° (norm 60), Rotation R 55° (norm 80), Rotation L 60° (norm 80), Lateral Flexion R 30° (norm 45), Lateral Flexion L 35° (norm 45). Palpation: tenderness bilateral upper trapezius and suboccipital. Vestibular: Dix-Hallpike negative, BPPV negative, mild dizziness with rapid horizontal head turns. Balance: Single Leg Stance R 15 sec, L 12 sec (>30 sec norm). DGI 20/24 (mild impairment).
* **Diagnoses:** Cervicalgia; Cervicogenic dizziness; Vestibular dysfunction, post-concussion type.
* **Plan/Assessment:** PT 2x/week for 8 weeks. Interventions: vestibular rehabilitation, cervical stretching/strengthening, gaze stabilization, balance training. Goals: improve cervical ROM, decrease dizziness, enhance balance, return to prior activity.
* **Source References:** (DOC ID: PINEPT-20250728-001 | PAGE 7 of 42)

## Date of Medical Visit: 09/15/2025
### 09/15/2025
* **Type of Visit:** Neurology Follow-up
* **Facility Name:** Summit Neurology Associates
* **Provider Name:** Dr. Wendy Nakamura, MD
* **Subjective/HPI/CC/Hospital Course:** Reports further reduction in headache frequency to 1-2x/week. Finger tingling resolved since topiramate reduction. Significant improvement in dizziness attributed to vestibular PT. Cognitive function subjectively better. Plans to attempt part-time work next month.
* **Objective/PE:** Cranial nerves normal. Motor 5/5. Sensory WNL. Cervical ROM improved. No nystagmus.
* **Diagnoses:** Post-traumatic headache, significantly improved; Post-concussion syndrome, improving; Cervicogenic dizziness, resolved.
* **Plan/Assessment:** Continue current medication regimen. Consider gradual topiramate taper if headaches well-controlled. Support return to part-time work with accommodations. Follow-up in three months.
* **Source References:** (DOC ID: SUMMIT-NEURO-20250915-001 | PAGE 10 of 42)

## Date of Medical Visit: 10/20/2025
### 10/20/2025
* **Type of Visit:** Occupational Medicine - Return-to-Work Evaluation
* **Facility Name:** Ridgeview Occupational Medicine
* **Provider Name:** Dr. Frank Delgado, MD, MPH
* **Subjective/HPI/CC/Hospital Course:** Assessment for fitness for duty for planned return to part-time office work. Previously data analyst. Headaches and cognitive abilities improved. Concerns about screen time tolerance and multitasking capacity.
* **Objective/PE:** Physical exam unremarkable. Neurological normal. Functional capacity: sitting tolerance 2 hours before 10-min break. Sustained attention adequate for simple tasks, decreased for complex. Screen tolerance: headache after ~90 minutes.
* **Diagnoses:** Post-concussion syndrome, recovery phase; Fitness for modified duty.
* **Plan/Assessment:** Cleared for part-time work 4 hours/day. Restrictions: frequent screen breaks every 60-90 min, written instructions, quiet work environment, no driving for work. Re-evaluation in 8 weeks.
* **Source References:** (DOC ID: RIDGEVIEW-OM-20251020-001 | PAGE 11 of 42)

## Date of Medical Visit: 12/10/2025
### 12/10/2025
* **Type of Visit:** Neurology Follow-up
* **Facility Name:** Summit Neurology Associates
* **Provider Name:** Dr. Wendy Nakamura, MD
* **Subjective/HPI/CC/Hospital Course:** Patient reports employed part-time for six weeks. Headaches infrequent (~1/week), mild. No dizziness. Cognitive function adequate for workload, some difficulty with longer meetings. Tolerates topiramate 25mg BID well.
* **Objective/PE:** Physical/neurological exam normal. MMSE 30/30.
* **Diagnoses:** Post-traumatic headache disorder, nearing resolution; Post-concussion cognitive impairment, mild residual symptoms.
* **Plan/Assessment:** Initiate topiramate taper: 25mg daily x 2 weeks, then 25mg every other day x 2 weeks, then discontinue. Continue Magnesium Glycinate 400mg daily. Recommend follow-up with occupational medicine for full duty assessment. Consider repeat neuropsychological testing in ~6 months.
* **Medication(s):** Topiramate taper as above; Magnesium Glycinate 400mg daily; Sumatriptan 50mg PRN.
* **Source References:** (DOC ID: SUMMIT-NEURO-20251210-001 | PAGE 13 of 42)

## Date of Medical Visit: 02/18/2026
### 02/18/2026
* **Type of Visit:** Occupational Medicine - Final Work Capacity Evaluation
* **Facility Name:** Ridgeview Occupational Medicine
* **Provider Name:** Dr. Frank Delgado, MD, MPH
* **Subjective/HPI/CC/Hospital Course:** Re-evaluation for progression to full-time employment. Reports worked part-time (4 hours/day) for four months without issues. Headaches rare (2-3x/month). Off topiramate for 4 weeks. Denies dizziness or cognitive complaints at current workload.
* **Objective/PE:** Physical exam entirely normal. Functional capacity: sitting tolerance 4+ hours with standard breaks. Screen tolerance >3 hours. Attention screening WNL.
* **Diagnoses:** Post-concussion syndrome, nearly resolved; Cleared for full-time duty with minimal restrictions.
* **Plan/Assessment:** Cleared for full-time work (8 hours/day). Recommendations: ergonomic workstation, screen breaks every 2 hours, no driving restrictions. Final neurologist follow-up recommended to close case.
* **Source References:** (DOC ID: RIDGEVIEW-OM-20260218-001 | PAGE 15 of 42)